" class="no-js "lang="en-US"> Cumulus Neuroscience - Medtech Alert
Thursday, March 30, 2023
Cumulus Neuroscience | Pharmtech Focus

Cumulus Neuroscience

About Cumulus Neuroscience

Cumulus Neuroscience

We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry.

Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.

Related Story

Cumulus Neuroscience Appoints Digital Health and Pharmaceutical Executive Aman Bhatti, MD as Chief Executive Officer

September 22 2022

Cumulus Neuroscience (Cumulus; the Company), a global digital health company developing multi-domain digital biomarkers for the […]

Cumulus Neuroscience Announces £6 million Funding Round

May 5 2021

Cumulus Neuroscience (Cumulus, The Company), formerly known as BrainWaveBank, announces a £6m financing round led […]